OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transforming Growth Factor Beta Receptor 3 (TGFBR3)–Associated Membranous Nephropathy
Tiffany Caza, Samar Hassen, Daniel J. Kenan, et al.
Kidney360 (2021) Vol. 2, Iss. 8, pp. 1275-1286
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Membranous nephropathy: new pathogenic mechanisms and their clinical implications
Elion Hoxha, Linda Reinhard, Rolf A.K. Stahl
Nature Reviews Nephrology (2022) Vol. 18, Iss. 7, pp. 466-478
Closed Access | Times Cited: 92

Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification
Sanjeev Sethi, Laurence H. Beck, Richard J. Glassock, et al.
Kidney International (2023) Vol. 104, Iss. 6, pp. 1092-1102
Open Access | Times Cited: 47

The lupus nephritis management renaissance
Juan M. Mejía‐Vilet, Ana Malvar, Arnon Arazi, et al.
Kidney International (2021) Vol. 101, Iss. 2, pp. 242-255
Closed Access | Times Cited: 67

Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry
Tiffany Caza, Aaron J. Storey, Samar Hassen, et al.
Kidney International (2023) Vol. 103, Iss. 3, pp. 593-606
Open Access | Times Cited: 41

Future landscape for the management of membranous nephropathy
Fernando Caravaca‐Fontán, Federico Yandián, Fernando C. Fervenza
Clinical Kidney Journal (2023) Vol. 16, Iss. 8, pp. 1228-1238
Open Access | Times Cited: 24

Mass Spectrometry With Data-Independent Acquisition for the Identification of Target Antigens in Membranous Nephropathy
Johann Morelle, Selda Aydın, Hanna Dêbiec, et al.
American Journal of Kidney Diseases (2025)
Open Access | Times Cited: 1

Netrin G1 Is a Novel Target Antigen in Primary Membranous Nephropathy
Linda Reinhard, Maya Machalitza, Thorsten Wiech, et al.
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 10, pp. 1823-1831
Open Access | Times Cited: 38

Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification
Sanjeev Sethi, Laurence H. Beck, Richard J. Glassock, et al.
Mayo Clinic Proceedings (2023) Vol. 98, Iss. 11, pp. 1671-1684
Open Access | Times Cited: 20

An Updated Review of Membranous Nephropathy
Orhan Efe, Paolo Nikolai So, Urmila Anandh, et al.
Indian Journal of Nephrology (2024) Vol. 34, pp. 105-118
Open Access | Times Cited: 7

Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis
Tiffany Caza, Chathura Wijewardena, Laith Al‐Rabadi, et al.
Translational research (2022) Vol. 245, pp. 55-81
Open Access | Times Cited: 23

Management of Lupus Nephritis: New Treatments and Updated Guidelines
Rupali S. Avasare, Yelena Drexler, Dawn J. Caster, et al.
Kidney360 (2023) Vol. 4, Iss. 10, pp. 1503-1511
Open Access | Times Cited: 12

Membranous nephropathy treatment standard
Yeshwanter Radhakrishnan, Ladan Zand, Sanjeev Sethi, et al.
Nephrology Dialysis Transplantation (2023) Vol. 39, Iss. 3, pp. 403-413
Closed Access | Times Cited: 11

Clinicopathologic features of non-lupus membranous nephropathy in a pediatric population
Paul Miller, Li Lei, Vivek Charu, et al.
Pediatric Nephrology (2022) Vol. 37, Iss. 12, pp. 3127-3137
Open Access | Times Cited: 17

Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment
Edmund Y. M. Chung, Yuan M. Wang, Karen Keung, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17

Novel Antigens and Clinical Updates in Membranous Nephropathy
Rupali S. Avasare, Nicole K. Andeen, Laurence H. Beck
Annual Review of Medicine (2023) Vol. 75, Iss. 1, pp. 219-332
Open Access | Times Cited: 10

Membranous nephropathy: pathogenesis and treatments
M.M. Wang, Jingjuan Yang, Xin Fang, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 3

The expanding spectrum and utility of antigens in membranous nephropathy
Paul Miller, Tiffany Caza
Current Opinion in Nephrology & Hypertension (2023) Vol. 32, Iss. 3, pp. 232-240
Closed Access | Times Cited: 8

Glomerular Exostosin-Positivity is Associated With Disease Activity and Outcomes in Patients With Membranous Lupus Nephritis
Xi Xia, Suchun Li, Zhipeng Wang, et al.
Kidney International Reports (2024) Vol. 9, Iss. 4, pp. 1040-1046
Open Access | Times Cited: 2

How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy
Tiffany Caza, Laith Al‐Rabadi, Laurence H. Beck
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16

Introduction of a novel chimeric active immunization mouse model of PLA2R1-associated membranous nephropathy
Nicola M. Tomas, Annabel Schnarre, Silke Dehde, et al.
Kidney International (2023) Vol. 104, Iss. 5, pp. 916-928
Open Access | Times Cited: 6

NELL1 membranous nephropathy: clinical associations provide mechanistic clues
Nicole K. Andeen, Vanderlene L. Kung, Rupali S. Avasare
Frontiers in Nephrology (2024) Vol. 4
Open Access | Times Cited: 2

Prediagnostic Appearance of Thrombospondin Type-1 Domain 7A Autoantibodies in Membranous Nephropathy
Peter D. Burbelo, Stephen W. Olson, Jason M. Keller, et al.
Kidney360 (2022) Vol. 4, Iss. 2, pp. 217-225
Open Access | Times Cited: 6

THSD7A as a Promising Biomarker for Membranous Nephrosis
Shuiqing Jiang, Dehua Jiang, Zhiyuan Lian, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 11, pp. 3117-3135
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top